GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Advance Bio-Pharmaceutical Inc (ROCO:4186) » Definitions » Price-to-Operating-Cash-Flow

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Price-to-Operating-Cash-Flow : 108.21 (As of May. 26, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Taiwan Advance Bio-Pharmaceutical Price-to-Operating-Cash-Flow?

As of today (2024-05-26), Taiwan Advance Bio-Pharmaceutical's share price is NT$15.15. Taiwan Advance Bio-Pharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.14. Hence, Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow Ratio for today is 108.21.

The historical rank and industry rank for Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow or its related term are showing as below:

ROCO:4186' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 106.43   Med: 108.93   Max: 115
Current: 108.21

During the past 13 years, Taiwan Advance Bio-Pharmaceutical's highest Price-to-Operating-Cash-Flow Ratio was 115.00. The lowest was 106.43. And the median was 108.93.

ROCO:4186's Price-to-Operating-Cash-Flow is ranked worse than
89.66% of 290 companies
in the Biotechnology industry
Industry Median: 26.275 vs ROCO:4186: 108.21

Taiwan Advance Bio-Pharmaceutical's Cash Flow from Operations per share for the six months ended in Dec. 2023 was NT$0.45. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.14.

During the past 13 years, Taiwan Advance Bio-Pharmaceutical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.40% per year. The lowest was -170.30% per year. And the median was -3.95% per year.


Taiwan Advance Bio-Pharmaceutical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Advance Bio-Pharmaceutical Price-to-Operating-Cash-Flow Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 121.07

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 121.07

Competitive Comparison of Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow falls into.



Taiwan Advance Bio-Pharmaceutical Price-to-Operating-Cash-Flow Calculation

Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=15.15/0.14
=108.21

Taiwan Advance Bio-Pharmaceutical's Share Price of today is NT$15.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Taiwan Advance Bio-Pharmaceutical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Taiwan Advance Bio-Pharmaceutical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Business Description

Traded in Other Exchanges
N/A
Address
12F., No.25, Ln. 169, Kangning Street, Xizhi Dist, New Taipei City, TWN, 22180
Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's product includes Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Headlines

No Headlines